astragaloside a has been researched along with cytarabine in 1 studies
| Studies (astragaloside a) | Trials (astragaloside a) | Recent Studies (post-2010) (astragaloside a) | Studies (cytarabine) | Trials (cytarabine) | Recent Studies (post-2010) (cytarabine) |
|---|---|---|---|---|---|
| 675 | 5 | 573 | 15,487 | 2,424 | 3,188 |
| Protein | Taxonomy | astragaloside a (IC50) | cytarabine (IC50) |
|---|---|---|---|
| nuclear receptor coactivator 3 isoform a | Homo sapiens (human) | 7.533 | |
| E3 ubiquitin-protein ligase Mdm2 | Homo sapiens (human) | 0.02 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, W; Dong, JJ; Jin, XJ; Li, CH; Li, GQ; Li, JJ; Li, JW; Li, L; Li, YL; Liu, YQ; Zhang, JB; Zhang, M | 1 |
1 other study(ies) available for astragaloside a and cytarabine
| Article | Year |
|---|---|
Astragaloside IV alleviates cytarabine-induced intestinal mucositis by remodeling macrophage polarization through AKT signaling.
Topics: Animals; Cytarabine; Inflammation; Lipopolysaccharides; Macrophages; Membrane Proteins; Mice; Molecular Docking Simulation; Mucositis; Proto-Oncogene Proteins c-akt | 2023 |